During the past decade, University Medical Center Brackenridge conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 11 clinical trials were completed, i.e. on average, 275% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center Brackenridge" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Point Biomedical" with 3 trials sponsored, "University of California, San Francisco" with 2 trials sponsored, "University of Minnesota" with 2 trials sponsored and "Alexion" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center Brackenridge" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center Brackenridge" are "Cervical Adenocarcinoma" (3 trials), "Cervical Adenosquamous Carcinoma" (3 trials), "Coronary Artery Disease" (3 trials), "Recurrent Cervical Carcinoma" (3 trials) and "Stage IVB Cervical Cancer" (3 trials). Many other conditions were trialed in "University Medical Center Brackenridge" in a lesser frequency.

Most popular intervention types in "University Medical Center Brackenridge" are "Drug" (12 trials), "Other" (9 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "placebo" (4 trials), "Bevacizumab" (2 trials), "PB127 for Injectable Suspension" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center Brackenridge" are 21 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University Medical Center Brackenridge". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in University Medical Center Brackenridge, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center Brackenridge, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

University Medical Center Brackenridge has several departments that took part in Clinical trials: "Seton Institute for Plastic and Reconstructive Surgery" - 3 trials